abstract |
The present invention relates to new 3-, 10- and / or 12a-substituted tetracycline compounds. These tetracycline compounds are used to treat a variety of conditions that are sensitive to tetracycline compounds, such as bacterial infections and neoplasms, as well as other known applications of minocycline and tetracycline compounds, such as blocking tetracycline clearance and modulating gene expression. |